相似文献
1
Cardiovascular remodelling in coronary artery disease and heart failure.
Lancet. 2014 May 31;383(9932):1933-43. doi: 10.1016/S0140-6736(14)60107-0. Epub 2014 May 13.
2
Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Cardiovasc Res. 2016 Aug 1;111(3):217-26. doi: 10.1093/cvr/cvw161. Epub 2016 Jun 14.
3
High-intensity interval training increases myocardial levels of Klotho and protects the heart against ischaemia-reperfusion injury.
Exp Physiol. 2020 Apr;105(4):652-665. doi: 10.1113/EP087994. Epub 2020 Mar 17.
4
Preconditioning and postconditioning: underlying mechanisms and clinical application.
Atherosclerosis. 2009 Jun;204(2):334-41. doi: 10.1016/j.atherosclerosis.2008.10.029. Epub 2008 Nov 5.
5
Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction.
Cardiovasc Res. 2012 Dec 1;96(3):466-75. doi: 10.1093/cvr/cvs272. Epub 2012 Aug 21.
6
Approaches to the prevention of coronary vascular dysfunction caused by myocardial ischaemia and reperfusion.
Curr Pharm Des. 1999 Dec;5(12):1077-87.
7
Matrix metalloproteinases in cardiovascular disease.
Can J Cardiol. 2006 Feb;22 Suppl B(Suppl B):25B-30B. doi: 10.1016/s0828-282x(06)70983-7.
8
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29.
9
Mitochondria "THE" target of myocardial conditioning.
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1215-H1231. doi: 10.1152/ajpheart.00124.2018. Epub 2018 Jul 13.
10
Remodelling and adverse remodelling in CAD.
Herz. 2012 Sep;37(6):590-6. doi: 10.1007/s00059-012-3660-7.
引用本文的文献
1
Prognostic role of angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with acute myocardial infarction.
Front Cardiovasc Med. 2025 Aug 12;12:1515693. doi: 10.3389/fcvm.2025.1515693. eCollection 2025.
2
Alpha-ketoglutarate protects against myocardial infarction via FTO-mediated anti-inflammatory macrophage activation.
Basic Res Cardiol. 2025 Aug 16. doi: 10.1007/s00395-025-01135-8.
3
Compound Danshen Tablets ameliorate myocardial ischemia/reperfusion injury-induced ventricular remodeling by regulating autophagy via AMPK/mTOR signaling pathway.
Chin Herb Med. 2024 Apr 24;17(3):548-554. doi: 10.1016/j.chmed.2024.03.003. eCollection 2025 Jul.
4
Identification of a key smooth muscle cell subset driving ischemic cardiomyopathy progression through single-cell RNA sequencing.
Sci Rep. 2025 Jul 27;15(1):27331. doi: 10.1038/s41598-025-09928-6.
5
Vascular (dys)function in the failing heart.
Nat Rev Cardiol. 2025 Jun 22. doi: 10.1038/s41569-025-01163-w.
6
Energy metabolism in cardiovascular diseases: unlocking the hidden powerhouse of cardiac pathophysiology.
Front Endocrinol (Lausanne). 2025 Jun 5;16:1617305. doi: 10.3389/fendo.2025.1617305. eCollection 2025.
7
The contribution of cardiomyocyte hypercontracture to the burden of acute myocardial infarction: an update.
Basic Res Cardiol. 2025 Jun 7. doi: 10.1007/s00395-025-01120-1.
8
Mechanical unloading is accompanied by reverse metabolic remodelling in the failing heart: Identification of a novel citraconate-mediated pathway.
Eur J Heart Fail. 2025 Jul;27(7):1342-1352. doi: 10.1002/ejhf.3704. Epub 2025 Jun 4.
9
Specialized Pro-Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential.
Acta Physiol (Oxf). 2025 Jul;241(7):e70062. doi: 10.1111/apha.70062.
10
Cardiac rehabilitation in porcine models: Advances in therapeutic strategies for ischemic heart disease.
Zool Res. 2025 May 18;46(3):576-607. doi: 10.24272/j.issn.2095-8137.2024.387.
本文引用的文献
1
Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial.
Circulation. 2013 Oct 22;128(17):1889-96. doi: 10.1161/CIRCULATIONAHA.113.001690. Epub 2013 Sep 25.
2
Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention.
Eur Heart J. 2014 Jan;35(3):168-75. doi: 10.1093/eurheartj/eht369. Epub 2013 Sep 12.
3
Postconditioning attenuates no-reflow in STEMI patients.
Basic Res Cardiol. 2013 Nov;108(6):383. doi: 10.1007/s00395-013-0383-8. Epub 2013 Sep 11.
4
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Circulation. 2013 Oct 1;128(14):1495-503. doi: 10.1161/CIRCULATIONAHA.113.003653. Epub 2013 Sep 3.
5
Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial.
Lancet. 2013 Aug 17;382(9892):597-604. doi: 10.1016/S0140-6736(13)61450-6.
6
Aspirate from human stented native coronary arteries vs. saphenous vein grafts: more endothelin but less particulate debris.
Am J Physiol Heart Circ Physiol. 2013 Oct 15;305(8):H1222-9. doi: 10.1152/ajpheart.00358.2013. Epub 2013 Aug 9.
7
Myocardial conditioning: opportunities for clinical translation.
Circ Res. 2013 Aug 2;113(4):439-50. doi: 10.1161/CIRCRESAHA.113.300764.
8
Collagenases and cracks in the plaque.
J Clin Invest. 2013 Aug;123(8):3201-3. doi: 10.1172/JCI67526. Epub 2013 Aug 1.
9
Novel aspects of excitation-contraction coupling in heart failure.
Basic Res Cardiol. 2013 Jul;108(4):360. doi: 10.1007/s00395-013-0360-2. Epub 2013 Jun 6.
10
Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction.
J Histochem Cytochem. 2013 Aug;61(8):555-70. doi: 10.1369/0022155413493912. Epub 2013 May 28.
Zotero 插件